Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Proceedings. Biological Sciences|May 26, 2001
Very high mutation rate in offspring of Chernobyl accident liquidatorsH S Weinberg, A B Korol, V M Kirzhner, et al.
Clinical Genetics|December 16, 2010
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndromeL Raskin, F Schwenter, M Freytsis, et al.
The American Journal of Pathology|October 5, 2001
Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profilesT J Giordano, K A Shedden, D R Schwartz, et al.
Community Genetics|August 28, 2004
Cancer genetics service provision: a comparison of seven European centresP Hopwood, C J van Asperen, G Borreani, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
ESMO Open|March 5, 2022
Artificial intelligence for detection of microsatellite instability in colorectal cancer-a multicentric analysis of a pre-screening tool for clinical applicationA Echle, N Ghaffari Laleh, P Quirke, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Endoscopy|December 6, 2012
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication, L von Karsa, J Patnick, et al.
British Journal of Cancer|June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter studyA Jakubowska, D Rozkrut, A Antoniou, et al.
Pageof 8